BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37882056)

  • 1. FDG PET/CT in a Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor.
    Guo J; Liao Z; Chen Q; Dong A; Huang M
    Clin Nucl Med; 2023 Dec; 48(12):1111-1113. PubMed ID: 37882056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior Identification of Metastatic Lesions by 68 Ga-FAPI-46 to 18 F-FDG PET/CT in a Case of SMARCA4-Deficient Undifferentiated Carcinoma of Stomach.
    Pang Y; Cai J; Zhao L; Xu W; Chen H
    Clin Nucl Med; 2023 Nov; 48(11):1009-1011. PubMed ID: 37703493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 68 Ga-DOTA-FAPI-04 PET/CT in the Detection of Thoracic SMARCA4-Deficient Undifferentiated Tumor.
    Shen X; Yang Z; Li N
    Clin Nucl Med; 2023 Dec; 48(12):1102-1104. PubMed ID: 37846457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients.
    Crombé A; Alberti N; Villard N; Pilleul F; Buy X; Le Loarer F; Kind M
    Eur Radiol; 2019 Sep; 29(9):4730-4741. PubMed ID: 30762113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thoracic SMARCA4-deficient undifferentiated tumor resembling malignant lymphoma].
    Asou C; Maeda T; Yamaguchi O; Okamura D; Ishikawa M; Kohri M; Tsukasaki K; Matsuda A; Asou N; Satoh T; Kayano H; Takahashi N
    Rinsho Ketsueki; 2023; 64(4):271-276. PubMed ID: 37121771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMARCA4-deficient thoracic tumor detected by [
    Okazaki T; Yokoyama K; Tsuchiya J; Honda T; Ishikawa Y; Kirimura S; Miyazaki Y; Tateishi U
    Eur J Hybrid Imaging; 2021 Apr; 5(1):8. PubMed ID: 34181162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An aggressive case of a thoracic undifferentiated SMARCA4-deficient tumor with extensive pleural involvement.
    Hanona PF; Ezekwudo D; Fullmer J; Allen T; Jaiyesimi I
    Thorac Cancer; 2024 Apr; 15(10):847-851. PubMed ID: 38390699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoracic SMARCA4-deficient undifferentiated tumor: current knowledge and future perspectives.
    Shinno Y; Ohe Y;
    Jpn J Clin Oncol; 2024 Mar; 54(3):265-270. PubMed ID: 38117955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMARCA4-deficient undifferentiated tumor that responded to chemotherapy in combination with immune checkpoint inhibitors: A case report.
    Utsumi T; Taniguchi Y; Noda Y; Fukai M; Kibata K; Murakawa T
    Thorac Cancer; 2022 Aug; 13(15):2264-2266. PubMed ID: 35778998
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Nakra T; Kakkar A; Mathur SR; Jain D; Kumar S
    Int J Surg Pathol; 2023 Feb; 31(1):104-109. PubMed ID: 35466749
    [No Abstract]   [Full Text] [Related]  

  • 11. SMARCA4-deficient tumors in the adrenal gland and small intestines: A rare case report.
    Kambe A; Yamamoto Y; Hasegawa C; Kakiuchi A; Kojima D; Hino A; Horikawa A; Doiuchi T; Kurihara H
    Radiol Case Rep; 2024 Feb; 19(2):794-797. PubMed ID: 38111549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.
    Sauter JL; Graham RP; Larsen BT; Jenkins SM; Roden AC; Boland JM
    Mod Pathol; 2017 Oct; 30(10):1422-1432. PubMed ID: 28643792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities.
    Yoshida A; Kobayashi E; Kubo T; Kodaira M; Motoi T; Motoi N; Yonemori K; Ohe Y; Watanabe SI; Kawai A; Kohno T; Kishimoto H; Ichikawa H; Hiraoka N
    Mod Pathol; 2017 Jun; 30(6):797-809. PubMed ID: 28256572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
    Khor LK; Loi HY; Sinha AK; Tong KT; Goh BC; Loh KS; Lu SJ
    Head Neck; 2016 Apr; 38(4):E76-80. PubMed ID: 26275126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of cell block examination for the cytological diagnosis of thoracic SMARCA4-deficient undifferentiated tumor: A case report.
    Minoshima A; Sugita S; Segawa K; Aoyama T; Ito M; Daimon F; Takenami T; Kido T; Moriya J; Nishikiori H; Hasegawa T
    Diagn Cytopathol; 2023 May; 51(5):E149-E154. PubMed ID: 36772934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature.
    Stewart BD; Kaye F; Machuca T; Mehta HJ; Mohammed TL; Newsom KJ; Starostik P
    Int J Surg Pathol; 2020 Feb; 28(1):102-108. PubMed ID: 31382829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytopathological Features of
    Takeda M; Tani Y; Saijo N; Shimizu S; Taniguchi Y; Otsuka K; Nakao K; Tamiya A; Okishio K; Atagi S; Ohbayashi C; Kasai T
    Int J Surg Pathol; 2020 Feb; 28(1):109-114. PubMed ID: 31448657
    [No Abstract]   [Full Text] [Related]  

  • 18. Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.
    Kito Y; Kawashima K; Saigo C; Hasegawa M; Nomura S; Mikamo T; Hanamatsu Y; Matsuo Y; Takeuchi T
    Diagn Pathol; 2022 Feb; 17(1):29. PubMed ID: 35151345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas.
    Nambirajan A; Dutta R; Malik PS; Bubendorf L; Jain D
    Acta Cytol; 2021; 65(1):67-74. PubMed ID: 32854100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thoracic SMARCA4-deficient undifferentiated tumors mimicking inflammatory lesions.
    Ma P; Cheng A; Song F; Sun Y
    Asian J Surg; 2024 May; 47(5):2290-2291. PubMed ID: 38331614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.